我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

罗格列酮对兔髂动脉球囊损伤术后脂联素表达及内膜增殖的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2009年第4期
页码:
462-466
栏目:
基础研究
出版日期:
2009-06-25

文章信息/Info

Title:
Effects of rosiglitazone on expression of adiponectin and intimal proliferation after balloon endothelial denudation of iliac artery in rabbits
作者:
曹选超; 丁世芳; 蒋桔泉; 陈志楠; 龚志刚
广州军区武汉总医院心内科，湖北 武汉 430070
Author(s):
CAO Xuan-chao;  DING Shi-fang;  JIANG Ju-quan;  CHEN Zhi-nan;  GONG Zhi-gang
Division of Cardiovascular Diseases, Wuhan General Hospital, Guangzhou Military Area Command, Wuhan 430070, Hubei, China
关键词:
罗格列酮; 过氧化物酶体增殖物激活受体γ; 兔; 脂联素
Keywords:
rosiglitazone;  peroxisome proliferator-activated receptor ;  rabbit;  adiponectin
分类号:
R972.4
DOI:
-
文献标识码:
A
摘要:
目的 观察罗格列酮对兔髂动脉球囊内膜剥脱术后，脂联素表达水平及内膜增殖的影响，并探讨罗格列酮预防血管再狭窄的可能机制。方法 将30只雄性新西兰大白兔随机分为3组，即正常对照组（给予普通饮食）、模型组（给予高脂饮食+球囊剥脱术）和罗格列酮组（给予高脂饮食+球囊剥脱术+罗格列酮）。分别于球囊损伤术后第1、4周，取血测定血脂、血糖；用ELISA法测定血浆脂联素的水平。取髂动脉标本进行病理形态学观察及弹力纤维染色。用免疫组化染色法测定增殖细胞核抗原（PCNA）的表达。结果 成功建立了兔髂动脉血管内皮损伤模型。与模型组兔相比，罗格列酮组在术后第1、4周末，总胆固醇（TC）、三酰甘油（TG）和低密度脂蛋白-胆固醇（LDL-C）等指标均明显降低（P<0.01），HE及弹力纤维染色提示，内膜增殖程度显著减轻，PCNA的表达减少，血浆脂联素的水平明显升高（P<0.05或P<0.01）。以上变化在术后4周末更为显著。结论 罗格列酮可有效抑制血管损伤后内膜的增殖，其机制可能与通过PPARγ途径增加脂联素的表达水平有关。
Abstract:
AIM: To study the effects of rosiglitazone on the expression of adiponectin and intimal proliferation after balloon endothelial denudation in rabbits and to explore the mechanism of rosiglitazone in preventing restenosis. METHODS: Thirty male New Zealand white rabbits were randomly divided into control group (normal diet), model group (hypercholesterol diet plus balloon endothelial denudation) and rosiglitazone group (balloon endothelial denudation plus hypercholesterol diet supplemented with rosiglitazone). Serum lipids and adiponectin levels were measured at 1 week and 4 weeks after balloon endothelial injury. Local iliac arteries were sectioned for the analysis of pathological morphology and were stained for PCNA immunohistochemistrical analysis. RESULTS: Hypercholesterolemia was successfully induced. After rosiglitazone intervention, significant difference was found in the levels of serum TC, TG and LDL-C between model and rosiglitazone groups (P<0.01). Compared with those in the model group, expression of PCNA in rosiglitazone group was significantly lowered and expression of adiponectin significantly increased (P<0.05). These changes were more significant by the end of the 4th week after balloon endothelial denudation. CONCLUSION: Rosiglitazone efficiently inhibits intimal proliferation during restenosis after balloon injury, which may be related to the increasing expression of adiponectin.

参考文献/References

［1］ Pischon T, Schulze MB, Rimm EB. Letter by Pischon et al regarding article, “Adiponectin and coronary heart disease: a prospective study and meta-analysis”［J］. Circulation, 2007, 115(10):e322.

［2］ Chen SW, Li XH, Ye KH, et al. Total saponins of Panax notoginseng protected rabbit iliac artery against balloon endothelial denudation injury［J］. Acta Pharmacol Sin, 2004, 25 (9):1151-1156.

［3］ Libby P, Theroux P. Pathophysiology of coronary artery disease［J］. Circulation, 2005, 111(25):3481-3488.

［4］ Boyle PJ, KingAB, Olansky L, et al. Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus :a retrospective review of randomly selected medical records［J］ . Clin Ther, 2002, 24(3):378-396 .

［5］ 布伦，贾国良，韩淑芳,等. 罗格列酮对大鼠颈动脉球囊损伤后平滑肌细胞增殖和凋亡的影响［J］. 心脏杂志, 2007, 19(5):510-512.

［6］ Weintraub WS. The pathophysiology and burden of restenosis［J］. Am J Cardiol, 2007, 100(5A):3K-9K.

［7］ Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis［J］. J Biol Chem, 2002, 277(40):37487-37491.

［8］ DiMascio L, Voermans C, Uqoezwa M, et al. Identification of adiponectin as a novel hemopoietic stem cell growth factor［J］. J Immunol, 2007, 178(6):3511-3520.

［9］ Yang WS, Jeng CY, Wu TJ, et al. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients［J］. Diabetes Care, 2002, 25(2):376-380.

［10］Yilmaz MI, Sonmez A, Caglar K, et al. Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria［J］. Endocrine, 2004, 25(3):207-214.

备注/Memo

备注/Memo:
收稿日期：2008-12-11.通讯作者：丁世芳，主任医师，主要从事冠状动脉狭窄的研究Email：DSFMD@YaHoo.com.cn 作者简介：曹选超，在读硕士生Email:cxcppl@163.com
更新日期/Last Update: 2009-06-15